The linked FDA record identifies NOUVAG AG as the applicant for LipoSurg ARTIST, cleared under K254135 with a Substantially Equivalent decision dated 5 September 2026. The submission was received 22 December 2025 as a Traditional 510(k) reviewed by the General, Plastic Surgery panel, and the record notes a Summary statement. The applicant address in the filing is St. Gallerstrasse 25, 9403 Goldach, Switzerland, with Sankt Gallen listed as the city. NOUVAG's own site presents the company as Swiss medical technology and lists Goldach as its Swiss location. [1][3][8]
The documented filing
K254135 covers a device named LipoSurg ARTIST, classified as a suction lipoplasty system for removal under 21 CFR 878.5040, device class 2, product code QPB, with General, Plastic Surgery as the advisory committee and medical specialty. The decision code is SESE, described as Substantially Equivalent, and the clearance type is Traditional with no third-party review. The applicant contact listed is Christof Künz. [1][8][9]
A separate index entry states the indication for ARTIST as removal of tissue or fluid from the body during general surgical procedures, including suction lipoplasty for aesthetic body contouring. That indication text appears in the index source, not in the FDA record itself. [9]
Product context from the publisher
NOUVAG's website organizes offerings under Applications and Products, with liposuction listed under aesthetic surgery and suction and infiltration pumps listed as a product category. The LipoSurg page sits within the suction and infiltration pumps section and describes a range of suction and infiltration pumps for various applications, attributed to NOUVAG as solutions manufactured in Switzerland. [3][5]
The LipoSurg instructions for use document carries a NOUVAG AG copyright line with document number 31648 and version V20240624, and its symbol key covers items such as type BF applied parts, autoclavability at 134°C, ethylene oxide sterilization and single-use restrictions. The document does not establish clinical performance. [6]
Corporate identity and EU roles
NOUVAG's site lists NOUVAG AG at St. Gallerstrasse 25, 9403 Goldach, Switzerland, and NOUVAG GmbH at Schulthaißstrasse 15, 78462 Konstanz, Germany, with the German entity labeled EU-Representative and EU-Importer. The legal notice states that copyrights and other rights to site content belong exclusively to Nouvag AG or specifically named rights holders. [3][4][7]
The public documents do not identify any parent company, subsidiary ownership structure or brand hierarchy beyond the applicant name and the German entity's stated EU roles. [3][7]
What the record does and does not show
The supplied collection contains one linked 510(k) record, K254135, with a decision count of one SESE, and the record sample likewise contains that single entry. These counts describe the supplied filings as of the snapshot date and are not measures of total company sales, total portfolio or safety performance. [1]
An index source lists related records for LipoSurg Artist Handpiece S3 and LipoSurg Artist Control Unit dated 18 September 2026, but those entries are not among the numbered sources and are not treated here as cleared filings. Commercial availability, customers and clinical outcomes are not established by the public information. [8]
